Dr Ricky Tirtakusuma Dr Katarzyna Szoltysek Professor Vasily Grinev Dr Sirintra Nakjang Dr Daniel Williamson et al. | Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia | 2022 |
|
Dr Britta Vormoor
| Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia | 2022 |
|
Dr Britta Vormoor Professor Gareth Veal Melanie Griffin Professor Julie Irving Lynne Minto et al. | A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia | 2017 |
|
Dr Britta Vormoor Yvonne Schlosser Dr Helen Blair Abhishek Sharma Sarah Wilkinson et al. | Sensitizing Ewing sarcoma to chemo- and radiotherapy by inhibition of the DNA-repair enzymes DNA protein kinase (DNA-PK) and poly-ADP-ribose polymerase (PARP) 1/2 | 2017 |
|
Dr Britta Vormoor Yvonne Schlosser Dr Helen Blair Sarah Wilkinson Professor Herbie Newell et al. | Inhibition of DNA-Repair Enzymes (DNA-Pk and Parp) to Sensitize Ewing Sarcoma to Chemo-And Radiotherapy | 2015 |
|
Dr Jeyanthy Eswaran Dr Paul Sinclair Professor Olaf Heidenreich Professor Julie Irving Dr Lisa Russell et al. | The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia | 2015 |
|
Dr Britta Vormoor Henrike Knizia Michael Batey Dr Ian Wilson Dr Petra Dildey et al. | Development of a Preclinical Orthotopic Xenograft Model of Ewing Sarcoma and Other Human Malignant Bone Disease Using Advanced In Vivo Imaging | 2014 |
|
Dr Britta Vormoor Dr Yan Zhao Professor Herbie Newell
| Evaluating the activity of the p53-MDM2 inhibitor NDD0005 in Ewing sarcoma | 2014 |
|
Dr Britta Vormoor Professor Nicola Curtin
| Poly(ADP-ribose) polymerase inhibitors in Ewing sarcoma | 2014 |
|
Dr Britta Vormoor Sarah Wilkinson Fiona Harvey Professor Ruth Plummer Professor Nicola Curtin et al. | Ewing's Sarcoma Cells Can Be Sensitized to Temozolomide and to a Lesser Extent to Radiotherapy by Co-treatment with a PARP-inhibitor (AG014699) | 2012 |
|
Dr Britta Vormoor Professor Nicola Curtin Professor Steven Clifford
| Sensitisation of paediatric solid tumours to DNA-damaging chemotherapy by inhibition of DNA-dependent protein kinase (PRKDC) | 2010 |
|
Dr Britta Vormoor
| Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95 | 2005 |
|
Dr Britta Vormoor
| Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture | 2003 |
|
Dr Britta Vormoor
| New treatment strategies in childhood acute lymphoblastic leukaemia | 2002 |
|
Dr Britta Vormoor
| Leukemias in children and adolescents | 1999 |
|